- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N), a developer of advanced nanomaterials and extended release nanotechnologies, today announced that President and Chief Technology Officer Cathy Fleischer, Ph.D. will be presenting at the Society of Plastics Engineers (SPE) Best of Polymer Nanocomposites Conference.
NaturalNano and one of its joint development partners, Noble Polymers, a fully owned subsidiary of Cascade Engineering (www.cascadeng.com), a leader in engineered plastic systems and components, are collaborating as part of the e-Learning series sponsored by the SPE focused on the applications of Halloysite Nanotubes (HNT(TM)) in Polymer composites. Fleischer's presentation is scheduled for 11 a.m. EST, Wednesday, Jan. 30, 2008.
"The growth of the plastics industry, coupled with the almost daily breakthroughs in nanocomposites, provides an excellent platform for NaturalNano to exhibit our industry-leading applications for Halloysite Nanotubes," said Fleischer. "It's an honor to be recognized as an expert source on the next generation of nanocomposites and to present with our partners Cascade Engineering, and we look forward to sharing our successes with the plastics industry."
Fleisher's presentation and findings are being co-authored by Noble Polymers, a leader in high-performance, customizable plastics solutions and a subsidiary of Grand Rapids, Mich.-based Cascade, Engineering, a leader in the development, engineering and manufacturing of plastics solutions. Cascade and Noble have validated the unique properties of NaturalNano's premiere product, Pleximer(TM), through manufacturing scale testing for multiple industries, including the furniture and automotive industries.
NaturalNano (www.naturalnano.com) said it will also highlight the numerous consumer industry applications of Pleximer, its patented turn-key nanocomposite additive which creates stronger, lighter and less expensive products. Pleximer has received multiple third-party validations by industry leaders for uses in multiple products, including Cascade Engineering and the Nylon Corporation of America.
To access the presentation, log on to: www.4spe.org/elearning/presentations/EL080130.php.
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N) is a materials science company focused on developing and commercializing advanced nanocomposites and extended release nanotechnologies. Based in Rochester, NY, the Company is focused on additive technologies and processes, including its proprietary Pleximer(TM) polymer additive, that add value to industrial polymers, plastics and composites, as well as consumer and industrial products. NaturalNano holds and licenses over 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite and other nanotubes.
Cautionary Statement Regarding Forward-Looking Statements: This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.
For more information, please click here
Lambert, Edwards & Associates
Copyright © MarketwireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Silicon-based metamaterials could bring photonic circuits February 1st, 2016
Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016